A 62-year-old woman is evaluated in the surgical intensive care unit for a new-onset fever. She underwent a complex exploratory laparotomy for a perforated viscus 6 days ago. Postoperatively, she required significant fluid resuscitation and vasopressor support, prompting the placement of a central venous catheter in the right internal jugular vein. She has been weaning off support, but today her temperature is 38.9°C (102°F), blood pressure is 94/62 mmHg, and heart rate is 114/min. The catheter insertion site shows no erythema or purulent drainage. Leukocyte count is 16,500/mm³. Paired blood cultures drawn from the central line and a peripheral vein are pending. The medical director of the ICU is currently implementing a quality improvement initiative to decrease the incidence of this patient's suspected hospital-acquired condition. Which of the following practices should be strictly enforced as part of the evidence-based insertion bundle to most effectively prevent this complication?
- Application of maximum sterile barrier precautions during catheter insertionCevap
- BAdministration of systemic prophylactic antibiotics 30 minutes prior to insertion
- CRoutine replacement of the central venous catheter over a guidewire every 7 days
- DPreferential utilization of the femoral vein instead of the subclavian vein for venous access
- ERoutine culturing of the catheter tip upon discontinuation in all patients